Through UChicago Argonne, LLC, the University of Chicago brings the best of commercial practices and marshals the talent of Illinois’ leading research universities to lead Argonne into the future.

News

Existing drug is shown to inhibit virus that causes COVID-19

Scientists from the University of Chicago have found that the drug masitinib may be effective in treating COVID-19.

The drug, which has undergone several clinical trials for human conditions but has not yet received approval to treat humans, inhibited the replication of SARS-CoV-2, the virus that causes COVID-19, in human cell cultures and in a mouse model, leading to much lower viral loads.

Published
Aug 2, 2021

July 2021 PSE Employees of the Month

The Physical Sciences and Engineering (PSE) Employees of the Month program recognizes individuals from two categories each month — programmatic and operations — based on the excellence of their work and demonstration of Argonne’s Core Values: Impact, Safety, Respect, Integrity and Teamwork.

July 2021 PSE Employee of the Month — Operations category

Published
Aug 2, 2021